Cargando…
Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
Semen analysis was performed in 14 men a median of 13.5 months after completion of VAPEC-B chemotherapy for Hodgkin's disease or non-Hodgkin's lymphoma. Semen from 12 patients contained motile spermatozoa, and in nine cases the count was > 20 million ml-1. One patient was azoospermic (V...
Autores principales: | Radford, J. A., Clark, S., Crowther, D., Shalet, S. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968681/ https://www.ncbi.nlm.nih.gov/pubmed/7507693 |
Ejemplares similares
-
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
por: Holmes, S. J., et al.
Publicado: (1994) -
Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
por: Cho, Hyungwoo, et al.
Publicado: (2016) -
Malignant Lymphomas other than Hodgkins's Disease
por: Crowther, D.
Publicado: (1981) -
The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.
por: Radford, J. A., et al.
Publicado: (1990) -
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)